REGENXBIO Announces Pipeline Expansion with RGX-181 Gene Therapy for CLN2 Form of Batten Disease https://t.co/c2fUupPV8d
— Marisa Peer (@PeerMarisa) August 30, 2018
from Twitter https://twitter.com/PeerMarisa
August 30, 2018 at 01:50AM
Thursday, August 30, 2018
REGENXBIO Announces Pipeline Expansion with RGX-181 Gene Therapy for CLN2 Form of Batten Disease https://t.co/c2fUupPV8d
from Twitter https://twitter.com/PeerMarisa
August 30, 2018 at 01:50AM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment